Nonetheless, factors like the ECM and tumor-derived molecules such as transforming growth factor beta (TGF-β) can inhibit CD8+ T cell activity, contributing to an immunosuppressive microenvironment (Joyce & Fearon, 2015; Mariathasan et al., 2018). The gene discussed is CD8A; the disease is neoplasm.